(Q52193737)
Statements
Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension (English)
N Glab
C Tréhin
C Perennes
J M Bureau
L Meijer
C Bergounioux